Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenesis via cytokine secretion refers to the process by which new blood vessels are formed from pre-existing vasculature, primarily driven by the release of signaling proteins known as cytokines. This mechanism is fundamental in both physiological processes (such as development and wound healing) and pathological conditions (including tumor growth and chronic inflammation). Key cytokines include VEGF, FGF-2, HGF-SF, Angiopoietins, IL-6, IGF-1, TNFα, and CXCL12/SDF‑1α. Cytokine secretion involves complex intracellular trafficking pathways. Hypoxia and activated immune cells can induce the secretion of angiogenic factors. The main receptors mediating responses to angiogenic cytokines include VEGFRs, FGFRs, and Tie‑receptors. Cytokine-driven angiogenesis supports normal tissue growth/development, wound healing and menstrual cycle changes. In pathology, it plays a role in tumor progression and chronic inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis via Cytokine Secretion.